Syndopa vs. Azilect: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Syndopa and Azilect. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 102,665 people who take Syndopa and Azilect, and is updated regularly.
What is Syndopa?
Syndopa has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 60 Syndopa users. Check the latest studies of Syndopa.
What is Azilect?
Azilect has active ingredients of rasagiline mesylate. It is often used in parkinson's disease. eHealthMe is studying from 8,622 Azilect users. Check the latest studies of Azilect.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
102,665 people who take Syndopa and Azilect are studied.
Drugs being compared in this study:
- Syndopa (carbidopa; levodopa)
- Azilect (rasagiline mesylate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Syndopa:
- not at all: 4.3 %
- somewhat: 22.63 %
- moderate: 38.41 %
- high: 28.04 %
- very high: 6.62 %
Azilect:
- not at all: 2.83 %
- somewhat: 25.51 %
- moderate: 36.03 %
- high: 21.86 %
- very high: 13.77 %
Want to compare Syndopa with Azilect?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
- Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Syndopa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Azilect:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on carbidopa; levodopa and rasagiline mesylate (the active ingredients of Syndopa and Azilect, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rabeprazole and Enbrel drug interactions for women aged 50-59 - a second ago
- Endometrial Cancer and Weight Increased - 7 seconds ago
- Chronic Lymphocytic Leukaemia and Haemoglobin Decreased - 8 seconds ago
- Could Tylenol cause Cataplexy? - 11 seconds ago
- Sustiva and Risperdal drug interactions for men aged 50-59 - 12 seconds ago
- Could Ceftriaxone cause Myelosuppression? - 19 seconds ago
- Claritin and Painful Chest for Men aged 40-49 - 20 seconds ago
- Claritin and Chest Tightness for Men aged 40-49 - 20 seconds ago
- Claritin and Chest Tightness Or Pressure for Men aged 40-49 - 20 seconds ago
- Claritin and Chest Discomfort for Men aged 40-49 - 21 seconds ago